In one of the first major tests of the new FDA leadership’s regulatory philosophy toward gene therapies for rare diseases, ...

Two months after Bristol Myers Squibb fended off a lawsuit which accused the drugmaker of using illegal tactics to protect ...

What kind of uptake can Gilead expect for its highly touted, long-acting HIV pre-exposure prophylaxis (PrEP) injection ...

Novo Nordisk is under fire over a Spanish obesity awareness campaign. | Novo Nordisk is under fire over a Spanish obesity ...

In opening Wednesday’s meeting, newly appointed ACIP chair Martin Kulldorff, Ph.D., leaned into the controversy surrounding U.S. vaccine policy following the COVID-19 pandemic and, more recently, ...

As part of a multi-year collaboration, GSK and India’s Bharat Biotech are redoubling their efforts to bring the world’s first malaria vaccine to more countries in need at affordable prices. | The ...

Saatchi & Saatchi Wellness announced Wednesday the appointments of three new leaders: Brendan Gallagher as president, Divya Dileep as chief creative officer and Beth Bour as the agency’s first-ever ...

La., has come out critical of Robert F. | Sen. Bill Cassidy, M.D., R-La., has come out critical of Robert F. Kennedy Jr.’s ...

With sales of its lone product in a precipitous decline in the United States, Amarin has turned to an experienced local ...

For the life sciences sector, the new initiatives are meant to work in concert with the upcoming 10-year plan for the ...

The new U.K. office will join more than a dozen others across the pond, including in Paris, Milan, Amsterdam and more.

Roche has demonstrated the power of combining two of oncology’s hottest modalities—bispecifics and antibody-drug conjugates ...